Merck plans copy of Rotateq in India

MSD Wellcome Trust Hilleman Laboratories, set up in India last year with support from Merck, will attempt to make a copy of the company's Rotateq vaccine for the prevention of diarrhea. Researchers there want to create a copycat that doesn't require refrigeration, making it more accessible to developing nations. Report

Suggested Articles

Merck & Co. inked a series of deals to advance three COVID-19 projects, trailing some of its large pharma peers into the industrywide research effort.

With a new £131 million contribution from the U.K. government, VMIC aims to both speed up and expand on its prior ambitions.

AstraZeneca scored a $1 billion contribution from the United States for development, production and delivery of its potential COVID-19 vaccine.